Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA Tissue

Keyphrases

• Aortic Valve Replacement 100%
• 5-year Outcomes 100%
• RESILIA 100%
• Life Sciences 60%
• Regurgitation 40%
• Structural Valve Deterioration 40%
• Core Laboratory 20%
• U.S. Food 20%
• Aortic Valve 20%
• Clinically Indicated 20%
• Echocardiogram 20%
• 30-day Mortality 20%
• Reintervention 20%
• All-cause Mortality 20%
• Follow-up Interval 20%
• Effective Orifice Area 20%
• Mortality Prediction 20%
• Investigational Device Exemption 20%
• New York Heart Association Functional Class 20%
• Clinically Stable 20%
• Society of Thoracic Surgeons 20%
• Clinical Event Committee 20%
• Hemodynamic Performance 20%
• Mean Gradient 20%
• Paravalvular Leak 20%
• Safety Performance 20%
• Bioprosthesis 20%
• Stable Haemodynamics 20%
• Surgical Aortic Valve Replacement 20%
• Aortic Bioprosthesis 20%
• Bovine Pericardium 20%
• Pericardial Bioprosthesis 20%
• Paravalvular 20%

Medicine and Dentistry

• Aortic Valve Replacement 100%
• All Cause Mortality 66%
• Valve Deterioration 66%
• Hemodynamic 66%
• Aortic Valve 33%
• Echocardiography 33%
• New York Heart Association Class 33%
• Apoplexy 33%
• Paravalvular Leak 33%
• Surgeon 33%